Tumor Necrosis Factor-a Signaling in Macrophages

Tumor necrosis factor-alpha (TNF alpha) was cloned over 2 decades ago and its identification in part led to the discovery of a super family of tumor necrosis factors (TNFs) and their receptors. TNF alpha signals through two transmembrane receptors, TNFR1 and TNFR2, and regulates a number of critical cell functions including cell proliferation, survival, differentiation, and apoptosis. Macrophages are the major producers of TNF alpha and interestingly are also highly responsive to TNF alpha. Aberrant TNF alpha production and TNF receptor signaling have been associated with the pathogenesis of several diseases, including rheumatoid arthritis, Crohn's disease, atherosclerosis, psoriasis, sepsis, diabetes, and obesity. TNF alpha has been shown to play a pivotal role in orchestrating the cytokine cascade in many inflammatory diseases and because of this role as a master-regulator of inflammatory cytokine production, it has been proposed as a therapeutic target for a number of diseases. Indeed anti-TNF alpha drugs are now licensed for treating certain inflammatory diseases including rheumatoid arthritis and inflammatory bowel disease. In this review we discuss the discovery of TNF alpha and its actions especially in regulating macrophage biology. Given its importance in several human diseases, we also briefly discuss the role of anti-TNF alpha therapeutics in the treatment of inflammatory diseases.